By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


pSivida Corp 

400 Pleasant Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-926-5000 Fax: 617-926-5050



Drug Delivery

Company News
pSivida (PSDV) Release; Durasert Three-Year Treatment For Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months 5/8/2017 9:00:27 AM
pSivida (PSDV) Reports Fiscal 2017 Third Quarter Results; Key Milestones On Track 5/5/2017 11:15:50 AM
pSivida (PSDV) To Report Third Quarter Fiscal Year 2017 Financial Results On Thursday, May 4th 4/20/2017 10:33:06 AM
pSivida (PSDV) To Present At The Ladenburg Thalmann Annual Healthcare Conference 9/22/2016 8:59:38 AM
Primary Endpoint Met in pSivida (PSDV)’s First Medidur Phase III 8/16/2016 7:48:23 AM
pSivida (PSDV) And Hospital For Special Surgery Innovation Center Announce Opening Of IND For Sustained-Release Implant For Severe Knee Osteoarthritis 8/2/2016 8:02:52 AM
pSivida (PSDV) Has Its Own Brexit, Consolidates U.K. Operations to Massachusetts HQ 7/26/2016 6:45:33 AM
pSivida (PSDV) CEO To Present At 18th Annual BIO CEO & Investor Conference February 9 1/29/2016 8:03:30 AM
pSivida (PSDV) Files Early European Regulator for Eye Care Device, Possibly to FDA As Well 12/29/2015 6:59:14 AM
pSivida (PSDV) Skyrockets on Phase III Medidur Trial Results 12/22/2015 9:27:03 AM